The role of chemo‐attractant lipoxygenase products in the pathogenesis of psoriasis
R. Camp,A. Mallet,F. Cunningham,E. Wong,P. Woollard,P. Dowd,A. Black,M. Greaves
DOI: https://doi.org/10.1111/j.1365-2133.1985.tb15634.x
IF: 11.113
1985-07-01
British Journal of Dermatology
Abstract:The histopathology of chronic, stable plaque psoriasis is characterized by acanthosis with mitotic figures in the lower epidermis, abnormalities of differentiation, vascular dilatation and tortuosity, and leukocyte infiltrates. These infiltrates are composed of neutrophils and mononuclear cells, the former apparently migrating from the dermal papilla, through the Malpighian layer and into the parakeratotic stratum corneum. Mononuclear cells are evident in the superficial dermis and in the lower half of the epidermis (Ragaz & Ackerman, 1979; Soltani & Van Scott, 1972; Helwig, 1958; Pinkus & Mehregan, 1966). The nature of the earliest histopathological change in developing psoriatic lesions is the subject of controversy with, for example, one group (Chowaniec et al, 1981) reporting infiltration of polymorphonuclear leukocytes into the epidermis to be the earliest change, another (Ragaz & Ackerman, 1979) finding a superficial perivascular lymphocyte infiltrate, and yet another (Brody, 1984a, b) reporting mast cell degranulation as the primary event in acute guttate psoriasis. In addition, Braun-Falco and Schmoeckel (1977) found macrophages to be the predominant infiammatory cells in initial psoriatic lesions. In postulating a role for an endogenously released chemical mediator in the genesis of a pathological change, it is important (i) to recover elevated levels of the mediator from the involved tissue in vivo at an appropriate time, (2) to reproduce at least in part the pathological change by introduction ofthe mediator into the tissue in vivo, in appropriate concentrations, (3) to demonstrate mechanisms for the release and removal of the mediator in the involved tissue, (4) to modify the pathological process by administration of specific enzyme inhibitors or receptor antagonists in vivo, (5) to determine the relative amounts of other chemical mediators with similar modes of action in the involved tissue in vivo and (6) to determine whether production ofthe mediator occurs in other lesions, i.e. whether it is specific to the pathological process under study. It is noteworthy that most ofthe above, which are an extension ofthe criteria of Dale (1934), can only be investigated by in vivo studies. We have chosen to examine the role of acidic lipid neutrophil chemo-attractants in the pathogenesis ofthe infiammatory changes in chronic plaque psoriasis. The evidence obtained to date is presented here in six sections, according to the above criteria.